In Vitro and In Vivo Activities of NS-718, a New Lipid Nanosphere Incorporating Amphotericin B, againstAspergillus fumigatus

Autor: Otsubo, Takakazu, Maesaki, Shigefumi, Hossain, Mohammad Ashraf, Yamamoto, Yoshihiro, Tomono, Kazunori, Tashiro, Takayoshi, Seki, Junzo, Tomii, Yoshifumi, Sonoke, Satoru, Kohno, Shigeru

Publikováno v: Antimicrobial Agents and Chemotherapy; March 1999, Vol. 43 Issue: 3 p471-475, 5p

ChemInform Abstract: Synthesis and Antibacterial Activity of Novel 7-Substituted 6-Fluoro-1-methylene-4-oxo-4H-[1,3]thiazeto [3,2-a]quinoline-3-carboxylic Acid Derivatives.

Autor: Matsuoka, Masato, Segawa, Jun, Aminoto, Isao, Masui, Yasushi, Tomii, Yoshifumi, Kitano, Masahiko, Kise, Masahiro

Publikováno v: ChemInform; Mar2000, Vol. 31 Issue 13, pno-no, 1p

In Vitro Antibacterial Activity of a New Quinolone, NM394

Autor: Ozaki, Masakuni, Matsuda, Masato, Tomii, Yoshifumi, Kimura, Kiyoshi, Kazuno, Kenji, Kitano, Masahiko, Kise, Masahiro, Shibata, Kazuo, Otsuki, Masako, Nishino, Takeshi

Publikováno v: Antimicrobial Agents and Chemotherapy; May 1992, Vol. 36 Issue: 5 p1170-1170, 1p

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS^®), with commercial lipid-based formulations

Autor: Fukui, Hiroshi h.fukui@po.nippon-shinyaku.co.jp, Koike, Tomohiro¹, Nakagawa, Takashi¹, Saheki, Akira¹, Sonoke, Satoru¹, Tomii, Yoshifumi¹, Seki, Junzo¹

Publikováno v: International Journal of Pharmaceutics. Nov2003, Vol. 267 Issue 1/2, p101. 12p.

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.

Autor: Fukui H; R&D Administration Department, Nippon Shinyaku Co. Ltd., 14 Nishinosho-Monguchi-cho Kisshoin, Minami-ku, Kyoto 601-8550, Japan. h.fukui@po.nippon-shinyaku.co.jp, Koike T, Nakagawa T, Saheki A, Sonoke S, Tomii Y, Seki J

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2003 Nov 28; Vol. 267 (1-2), pp. 101-12.